Skip to content
value.today

BGI Genomics Co., Ltd. vs NeoGenomics, Inc.

Add a company

Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.

In short

  • BGI Genomics Co., Ltd. is the larger company by market value: $2.4 B against $2.2 B for NeoGenomics, Inc., 1.1 times as much (market caps of Aug 1, 2026 for BGI Genomics Co., Ltd. and Oct 15, 2026 for NeoGenomics, Inc.). BGI Genomics Co., Ltd.'s value is the last on file, from Aug 1, 2026: no market-data feed is connected for its exchange yet.
  • BGI Genomics Co., Ltd. had more revenue: $985 M in the year to December 2021 against $727 M for NeoGenomics, Inc. in the year to December 2025.
  • BGI Genomics Co., Ltd. made a net profit of $213 M, while NeoGenomics, Inc. made a net loss of $108 M.
  • BGI Genomics Co., Ltd. keeps more of each dollar of sales: a net margin of 21.6% against -14.9% for NeoGenomics, Inc.
  • BGI Genomics Co., Ltd. employs more people: 3,585 against 2,000 at NeoGenomics, Inc. Each employee brings in about $274,756 of revenue at BGI Genomics Co., Ltd. and $363,665 at NeoGenomics, Inc.

Market value, the same start = 100

From Jan 2020: how each one's value moved, whatever its size.

0511031542052020202120222023202420252026BGI Genomics Co., Ltd. 63NeoGenomics, Inc. 72

Revenue by fiscal year

US$ billions, as reported in each year's annual results.

$0B$0B$0B$1B$1B201720182019202020212022202320242025NeoGenomics, Inc. $1B

Side by side

Side-by-side comparison; ▲ marks the best value of a measure where higher or lower is better
MeasureBGI Genomics Co., Ltd.
300676.SZ · #5,704 in the world
NeoGenomics, Inc.
NEO · #6,035 in the world
Profile
Country🇨🇳 China🇺🇸 USA
SectorHealthcareHealthcare
IndustryDiagnostics and ResearchDiagnostics and Research
Founded19992002
Size
Market cap$2.4 B$2.2 B
Revenue$985 M$727 M
Net income$213 M▲ best$-108 M
Employees3,5852,000
Valuation
P/E ratio11.3×—
Price to sales2.5×2.8×
Price to book1.8×2.6×
Free cash flow yield—-1.0%
Profitability
Gross margin—43.2%
Operating margin—-15.9%
Net margin—-14.8%
Return on equity—-12.4%
Growth
Revenue growth—10.1%
Revenue growth, 3 years a year—12.6%
Financial strength
Debt to equity—0.4×
Cash
Free cash flow margin—-3.0%
Strength scores
Piotroski F-score—4 of 9
Altman Z-score zone—grey
Data as ofMarket cap Aug 2026Market cap Oct 2026; ratios FY2025

Questions and answers#

Which is bigger, BGI Genomics Co., Ltd. or NeoGenomics, Inc.?

BGI Genomics Co., Ltd. is the larger company by market value: $2.4 B against $2.2 B for NeoGenomics, Inc., 1.1 times as much (market caps of Aug 1, 2026 for BGI Genomics Co., Ltd. and Oct 15, 2026 for NeoGenomics, Inc.). BGI Genomics Co., Ltd.'s value is the last on file, from Aug 1, 2026: no market-data feed is connected for its exchange yet.

Which makes more money, BGI Genomics Co., Ltd. or NeoGenomics, Inc.?

BGI Genomics Co., Ltd. had more revenue: $985 M in the year to December 2021 against $727 M for NeoGenomics, Inc. in the year to December 2025. BGI Genomics Co., Ltd. made a net profit of $213 M, while NeoGenomics, Inc. made a net loss of $108 M.

Which is more profitable, BGI Genomics Co., Ltd. or NeoGenomics, Inc.?

BGI Genomics Co., Ltd. keeps more of each dollar of sales: a net margin of 21.6% against -14.9% for NeoGenomics, Inc.

Which has more employees, BGI Genomics Co., Ltd. or NeoGenomics, Inc.?

BGI Genomics Co., Ltd. employs more people: 3,585 against 2,000 at NeoGenomics, Inc. Each employee brings in about $274,756 of revenue at BGI Genomics Co., Ltd. and $363,665 at NeoGenomics, Inc.